The global progressive pulmonary fibrosis (PPF) treatment market is projected to be valued at USD 4,044.6 Million in 2025 and is expected to reach USD 8,182.4 Million by 2035, registering a CAGR of 7.

Many individuals with chronic obstructive pulmonary disease describe exacerbations in personal, varied terms, revealing a ...

Bronchiectasis is one of the most neglected chronic lung diseases despite the fact it impacts 300,000 people in the UK ...

Researchers have found in two longitudinal cohorts that Incorporating chest CT imaging and respiratory symptoms into the ...

As summer travel peaks, doctors have urged residents with pre-existing health concerns to get medical clearance before flying ...

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.

Lung cancer is Australia’s fifth most diagnosed cancer, but causes the greatest number of deaths because it is often ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

Australia’s new lung cancer screen program further disadvantages Aboriginal and Torres Strait Islander peoples, who are ...

The UCLA advance opens the door to growing other vascularized organ models, including intestines and colons, providing ...

The UAB researchers showed that TREM2 — which stands for triggering receptors expressed on myeloid cells 2 — is predominantly ...

Researchers have developed a bacteria-specific PET tracer that distinguishes lung infections from inflammation, promising ...